Pharmaco - Press Releases

Date	Title	Company
06-Oct-2023	Marizyme, Inc. Announces FDA Clearance for Flagship Product, DuraGraft™	Marizyme, Inc.
06-Oct-2023	Bayer to partner with Twist Bioscience to accelerate drug discovery	Bayer
06-Oct-2023	Merck’s KEYTRUDA® (pembrolizumab) Met Primary Endpoint of Disease-Free Survival (DFS) in Certain Patients With Muscle-Invasive Urothelial Carcinoma (MIUC) After Surgery	Merck
06-Oct-2023	AbbVie Exercises Exclusive Right to Acquire Mitokinin, Further Strengthening Neuroscience Pipeline	AbbVie
06-Oct-2023	New data at WMS 2023 reaffirm long-term efficacy of Nexviazyme® (avalglucosidase alfa) for the treatment of Pompe disease	Sanofi
06-Oct-2023	Phase III studies to investigate survodutide for people living with obesity and overweight, with and without diabetes, cardiovascular disease and chronic kidney disease	Boehringer Ingelheim
06-Oct-2023	Pfizer Presents New Data at IDWeek 2023 Highlighting Advances in Prevention and Treatment of Certain Respiratory Illnesses and Other Infectious Diseases	Pfizer
06-Oct-2023	EYLEA® HD (AFLIBERCEPT) INJECTION 8 MG TWO-YEAR RESULTS FROM PIVOTAL PULSAR TRIAL IN WET AGE-RELATED MACULAR DEGENERATION PRESENTED AT EURETINA	Regeneron
06-Oct-2023	Patient Organizations Gave $22 Billion in Grants for Research, Patient Services, and Access to Care Over the Last 5 Years, Says IQVIA Institute for Human Data Science	IQVIA
06-Oct-2023	Researchers design potential therapy to prevent brain deterioration in children with rare genetic conditions	Francis Crick Institute
06-Oct-2023	Study proves: Cold plasma is a quantum leap for the treatment of chronic wounds	Viromed Medical AG
06-Oct-2023	Spexis to host business update conference call on October 9, 2023	Spexis AG
05-Oct-2023	Hoth Therapeutics Announces Merveille.ai Artificial intelligence Initiative for Drug Discovery	Hoth Therapeutics
05-Oct-2023	Impel Pharmaceuticals Announces Exploration of Strategic Alternatives	Impel Pharmaceuticals
05-Oct-2023	Biotest AG: Increase of the EBIT guidance	Biotest AG
05-Oct-2023	Biotest AG: Peter Janssen appointed new Chairman of the Board of Biotest AG	Biotest AG
05-Oct-2023	Veranova Announces Appointment of New Advisory Board	Veranova
05-Oct-2023	Empagliflozin (Jardiance®) receives positive NICE recommendation for treatment of symptomatic chronic heart failure with preserved or mildly reduced ejection fraction	Boehringer Ingelheim
05-Oct-2023	Terumo Blood and Cell Technologies launches study with BioCentriq(R) to generate public CAR-T cell data using Terumo BCT’s CGT manufacturing platforms	Terumo Blood and Cell Technologies
05-Oct-2023	EDX MEDICAL SIGNS AGREEMENT TO DISTRIBUTE CANCER GENOMIC TESTS FROM GUARDANT HEALTH IN UK AND NORDIC COUNTRIES	EDX Medical Group plc